Bleyer, Archie <br/><br/>
Epoetin versus darbepoetin conundrum compromise.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Sep 2006 
 - e46 p.  digital 
<br/><br/> Publication Type: Comment; Letter 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2006.07.5325  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anemia, Hypochromic--drug therapy<br/>Antineoplastic Agents--adverse effects<br/>Darbepoetin alfa<br/>Drug Administration Schedule<br/>Epoetin Alfa<br/>Erythropoietin--administration & dosage<br/>Hematinics--administration & dosage<br/>Humans<br/>Neoplasms--complications<br/>Randomized Controlled Trials as Topic<br/>Recombinant Proteins<br/>Treatment Outcome